SMTL ID : 5m2f.1

Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 30 residues within 4Å: Chain A: G.19, T.20, W.21, D.44, Y.49, K.78, H.111, S.160, N.161, Q.184, Y.210, S.211, P.212, L.213, G.214, S.215, P.216, D.217, L.229, A.246, I.261, P.262, K.263, S.264, V.265, T.266, R.269, E.272, N.273 Ligands: UV8.2 24 PLIP interactions: 24 interactions with chain A Hydrophobic interactions: A:W.21 Hydrogen bonds: A:T.20, A:W.21, A:D.44, A:D.44, A:Y.49, A:S.160, A:N.161, A:Q.184, A:S.211, A:L.213, A:S.215, A:D.217, A:S.264, A:V.265, A:T.266, A:T.266, A:E.272, A:N.273 Water bridges: A:T.244, A:R.269, A:R.269 Salt bridges: A:R.269 pi-Stacking: A:Y.210

1 x UV8: 3-bromo-4-[(1E)-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)prop-1-en-1-yl]benzoic acid(Non-covalent)

UV8.2: 13 residues within 4Å: Chain A: W.21, Y.49, W.80, H.111, W.112, F.123, P.124, R.125, G.129, A.131, L.301, L.302 Ligands: NAP.1 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:W.21, A:Y.49, A:W.80, A:W.80, A:F.123, A:R.125, A:A.131, A:L.301, A:L.302 Salt bridges: A:K.78, A:H.111 pi-Stacking: A:F.123

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 6 residues within 4Å: Chain A: E.6, L.7, S.8, G.204, I.205, T.206 2 PLIP interactions: 2 interactions with chain A Water bridges: A:T.206, A:N.257

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ruiz, F.X. et al., Structural basis for the inhibition of AKR1B10 by the C3 brominated TTNPB derivative UVI2008. Chem. Biol. Interact. (2017)

Release Date

2017-02-15

Peptides

Aldo-keto reductase family 1 member B10: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
X

Aldo-keto reductase family 1 member B10

Related Entries With Identical Sequence